Recorded Chinese product: 西尼地平软胶囊西尼地平软胶囊

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

西尼地平是一种在国家药监局注册认定的药品。该药品含有西尼地平-a68c0682等成分。

该药品关联的活性成分包括:西尼地平Xini Diping。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:大连美创药业有限公司Chinese legal name: 大连美创药业有限公司。

您可以探索含有相同成分的其他药品:西尼地平-a68c0682成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 西尼地平软胶囊) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 西尼地平Xini Diping.

Manufacturers recorded for this product: 大连美创药业有限公司Chinese legal name: 大连美创药业有限公司.

Explore other medicines containing the same ingredient: 西尼地平 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 西尼地平软胶囊Recorded Chinese product: 西尼地平软胶囊
  • 剂型Dosage form: 胶囊剂Capsules
  • 规格Specification: 5mg5 mg

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 大连美创药业有限公司Chinese legal name: 大连美创药业有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H20080705

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H20080705

Manufacturer

Chinese legal name: 大连美创药业有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H20080705

生产企业

大连美创药业有限公司(国产)

适应症

治疗原发性高血压、肾性高血压和心绞痛。

用法用量

口服给药:治疗原发性高血压:每次5~10mg,每天1次。必要时可增至每次20mg,每天1次。

不良反应

1.本药不良反应较轻,少数患者有面部潮红、头晕、恶心的表现。
2.在上市前的临床研究中,头痛发生率为3.7%。

禁忌

1.对本药及其他钙通道阻滞药过敏者;
2.高度主动脉瓣狭窄者。

注意事项

慎用:
1.老年患者;
2.肝、肾疾病患者;
3.孕妇;
4.充血性心力衰竭患者。

贮藏

密封,置阴凉处。

规格

5mg

证据Evidence

  • 批准文号: 国药准字H20080705
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.